These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15245779)

  • 1. Post-operative chemotherapy improves disease-free survival, but not overall survival in people with oesophageal squamous cell carcinoma.
    Leonard GD; Reilly EM
    Cancer Treat Rev; 2004 Aug; 30(5):473-7. PubMed ID: 15245779
    [No Abstract]   [Full Text] [Related]  

  • 2. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
    Iizuka N; Hirose K; Noma T; Hazama S; Tangoku A; Hayashi H; Abe T; Yamamoto K; Oka M
    Br J Cancer; 1999 Oct; 81(3):469-75. PubMed ID: 10507772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy for gastro-oesophageal cancer with epirubicin, cisplatin and fluorouracil: a single-centre experience.
    Strickland AH; Karapetis CS; Yip D; Harper PG
    Clin Oncol (R Coll Radiol); 2001; 13(1):66. PubMed ID: 11292143
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
    Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
    Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.
    Ando N; Iizuka T; Ide H; Ishida K; Shinoda M; Nishimaki T; Takiyama W; Watanabe H; Isono K; Aoyama N; Makuuchi H; Tanaka O; Yamana H; Ikeuchi S; Kabuto T; Nagai K; Shimada Y; Kinjo Y; Fukuda H;
    J Clin Oncol; 2003 Dec; 21(24):4592-6. PubMed ID: 14673047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Squamous cell cancer of the esophagus. Treatment concept at the Houston M.D. Anderson Cancer Center].
    Roth JA
    Chirurg; 1992 Sep; 63(9):683-8. PubMed ID: 1395872
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epidermoid cancer of the esophagus: role of radiotherapy and chemotherapy].
    Delouche D; Haefliger JM
    Rev Med Suisse Romande; 1998 Mar; 118(3):227-34. PubMed ID: 9594596
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma.
    Mariette C; Piessen G; Lamblin A; Mirabel X; Adenis A; Triboulet JP
    Br J Surg; 2006 Sep; 93(9):1077-83. PubMed ID: 16779882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neoadjuvant treatment of operable esophageal cancers].
    Azria D; Ychou M; Senesse P; Dubois JB
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1107-8. PubMed ID: 10592891
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
    Hsu FM; Lin CC; Lee JM; Chang YL; Hsu CH; Tsai YC; Lee YC; Cheng JC
    J Surg Oncol; 2008 Jul; 98(1):34-41. PubMed ID: 18449912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-myc gene amplification in different stages of oesophageal squamous cell carcinoma: prognostic value in relation to treatment modality.
    Bitzer M; Stahl M; Arjumand J; Rees M; Klump B; Heep H; Gabbert HE; Sarbia M
    Anticancer Res; 2003; 23(2B):1489-93. PubMed ID: 12820414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concomitant radiotherapy and chemotherapy with protracted low dose continuous infusion of 5-fluorouracil and cisplatin].
    Sueyama H; Sakai K; Hasegawa M; Tsuchida E; Ito T; Sugita T; Higuchi S; Fujita K
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2839-41. PubMed ID: 7993125
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the esophagus using low-dose FP and radiation: a preliminary report.
    Fujiwara Y; Kamikonya N; Inoue T; Koishi K; Yoshikawa R; Nakao K; Yagyu R; Nishiwaki M; Fujiwara M; Kojima S; Nakagawa K; Yamamura T
    Oncol Rep; 2005 Nov; 14(5):1177-82. PubMed ID: 16211282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Meta-analysis of postoperative adjuvant chemotherapy for localized esophageal carcinoma].
    Huang WZ; Fu JH; Hu Y; Zhang X; Yang H
    Ai Zheng; 2006 Oct; 25(10):1303-6. PubMed ID: 17059782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case report of esophageal carcinoma with grade 3 response by preoperative chemotherapy using CDDP/5-FU/LV].
    Bando K; Onda M; Miyashita M; Takahashi Y; Takita M; Matsutani T; Okawa K; Sasajima K; Ujihara Y; Takubo K; Yamashita K
    Gan To Kagaku Ryoho; 1998 May; 25(6):915-8. PubMed ID: 9617331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer.
    Sujendran V; Wheeler J; Baron R; Warren BF; Maynard N
    Br J Surg; 2008 Feb; 95(2):191-4. PubMed ID: 17948302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma.
    Lin CC; Yeh KH; Yang CH; Hsu C; Tsai YC; Hsu WL; Cheng AL; Hsu CH
    Anticancer Drugs; 2007 Jul; 18(6):703-8. PubMed ID: 17762400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significant role of cisplatin and 5-FU combination chemotherapy for first-line intensive treatment for advanced esophageal cancer].
    Matsui S; Iwazawa T; Yano H; Tono T; Nakano Y; Kanoh T; Kinuta M; Monden T
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1608-11. PubMed ID: 11707991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.